Items where authors include "Hurt, CN"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Willenbrock, F, Cox, CM, Parkes, EE et al. (10 more authors) (2021) Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. British Journal of Cancer, 124 (3). pp. 581-586. ISSN 0007-0920

Strauss, VY, Shaw, R, Virdee, PS et al. (13 more authors) (2019) Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine +/- nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer, 19. ARTN 121. ISSN 1471-2407

Prout, HC, Barham, A, Bongard, E et al. (15 more authors) (2018) Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials, 19 (1). ARTN 419. ISSN 1745-6215

Mukherjee, S, Hurt, CN, Gwynne, S et al. (15 more authors) (2017) NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74. pp. 38-46. ISSN 0959-8049

Neal, RD orcid.org/0000-0002-3544-2744, Barham, A, Bongard, E et al. (15 more authors) (2017) Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. British Journal of Cancer, 116 (3). pp. 293-302. ISSN 0007-0920

Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407

This list was generated on Sat Mar 23 22:43:52 2024 GMT.